Edition:
United States

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

863.15INR
22 Jul 2016
Change (% chg)

Rs12.55 (+1.48%)
Prev Close
Rs850.60
Open
Rs851.60
Day's High
Rs870.00
Day's Low
Rs842.70
Volume
578,885
Avg. Vol
611,782
52-wk High
Rs1,262.90
52-wk Low
Rs671.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 10.54 March 23 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 7 7 7
(2) OUTPERFORM 10 10 10 10
(3) HOLD 9 9 9 8
(4) UNDERPERFORM 2 2 2 2
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.31 2.31 2.31 2.29

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 2 23,593.30 23,864.30 23,322.30 --
Quarter Ending Mar-16 15 19,161.30 20,815.00 17,783.00 --
Year Ending Mar-16 27 73,673.40 82,766.00 71,066.00 --
Year Ending Mar-17 27 94,148.30 109,000.00 82,804.00 97,333.00
Year Ending Mar-18 26 105,742.00 139,000.00 92,951.00 107,655.00
Earnings (per share)
Quarter Ending Dec-16 2 10.54 12.19 8.89 --
Quarter Ending Mar-16 7 8.27 9.20 7.22 --
Year Ending Mar-16 30 29.82 34.00 26.20 --
Year Ending Mar-17 30 46.85 59.99 22.00 52.78
Year Ending Mar-18 28 52.79 67.07 45.20 57.64
LT Growth Rate (%) 3 28.03 38.57 19.10 31.65

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 19,161.30 21,740.20 2,578.96 13.46
Quarter Ending Dec-15 19,155.70 17,244.60 1,911.08 9.98
Quarter Ending Sep-15 18,421.20 18,440.20 18.97 0.10
Quarter Ending Jun-15 17,316.90 16,258.30 1,058.53 6.11
Quarter Ending Mar-15 17,746.50 17,537.90 208.59 1.18
Earnings (per share)
Quarter Ending Mar-16 8.27 6.08 2.19 26.44
Quarter Ending Dec-15 7.68 6.02 1.66 21.61
Quarter Ending Sep-15 7.66 7.10 0.56 7.28
Quarter Ending Jun-15 7.81 6.45 1.36 17.39
Quarter Ending Mar-15 6.22 7.27 1.05 16.84

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 23,593.30 23,321.70 23,321.70 23,321.70 --
Quarter Ending Mar-16 19,161.30 -- -- -- --
Year Ending Mar-16 73,673.40 -- -- -- --
Year Ending Mar-17 94,148.30 94,041.10 95,039.90 95,039.90 97,333.00
Year Ending Mar-18 105,742.00 105,537.00 104,957.00 104,957.00 107,655.00
Earnings (per share)
Quarter Ending Dec-16 10.54 10.51 11.48 11.48 --
Quarter Ending Mar-16 8.27 -- -- -- --
Year Ending Mar-16 29.82 -- -- -- --
Year Ending Mar-17 46.85 46.81 47.99 47.99 52.78
Year Ending Mar-18 52.79 52.71 53.12 53.12 57.64

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 2 0 2 0
Quarter Ending Mar-16 -- -- -- --
Year Ending Mar-16 -- -- -- --
Year Ending Mar-17 3 1 4 4
Year Ending Mar-18 4 0 6 0
Earnings
Quarter Ending Dec-16 1 1 1 1
Quarter Ending Mar-16 -- -- -- --
Year Ending Mar-16 -- -- -- --
Year Ending Mar-17 3 0 3 5
Year Ending Mar-18 3 1 3 5

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : GlobalData
$300.00
Provider : Reuters Investment Profile
$20.00
Provider : Sadif Analytics Prime
$10.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.